HIV Drug May Also Treat Macular Degeneration

The new study demonstrates that FDA-approved NRTIs stopped retinal degeneration, and researchers were surprised to find it was a previously unknown property of the drugs that produced the results. (Courtesy of Medical News Today)
The new study demonstrates that FDA-approved NRTIs stopped retinal degeneration, and researchers were surprised to find it was a previously unknown property of the drugs that produced the results. (Courtesy of Medical News Today)
The new study demonstrates that FDA-approved NRTIs stopped retinal degeneration, and researchers were surprised to find it was a previously unknown property of the drugs that produced the results. (Courtesy of Medical News Today)

(Medical News Today) – Reporting their findings in the journal Science, the international team, led by researchers at the University of Kentucky in Lexington, say because of a previously undiscovered property, the drugs may also be effective against other inflammatory disorders.

A major cause of vision loss among the elderly, age-related macular degeneration (AMD) is a progressive condition that is untreatable in up to 90% of patients. As AMD progresses, patients find their central vision becomes increasingly blurred and they struggle to read print, recognize people’s faces and drive a car.

There are two types of AMD: dry and wet. Dry is the most common and least serious form – it progresses slowly and accounts for 90% of cases. Wet AMD is more serious, and without treatment can progress very quickly. It develops when abnormal blood vessels invade the retina and cause cell damage.

READ MORE

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.